VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+36.78%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$171M
AUM Growth
+$171M
(-2%)
Cap. Flow
-$148K
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Glaukos
GKOS
$5.5B
| $77.6M | 45.39% | 3,136,232 -5,985 | -0.2% | -$148K |
|
|
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $45.3M | 26.52% | 1,092,152 | – | – |
|
3
Ocular Therapeutix
OCUL
$2.12B
| $20.8M | 12.15% | 2,215,384 | – | – |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $14.3M | 8.34% | 407,416 | – | – |
|
|
AKAO
5
DELISTED
Achaogen, Inc.
AKAO
| $7.35M | 4.3% | 1,281,152 | – | – |
|
|
BITI
6
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
| $3.86M | 2.26% | 268,672 | – | – |
|
|
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
| $1.77M | 1.04% | 1,048,601 | – | – |
|